The role of sympathetic beta-adrenergic receptor on renin secretion in essential hypertension
Shigetomi, S.; Hashimoto, S.; Fukuchi, S.
Nihon Jinzo Gakkai Shi 24(8): 929-936
1982
ISSN/ISBN: 0385-2385 PMID: 6294385 Document Number: 195738
Document emailed within 1 workday
Related Documents
K-Laflamme, A.; Oster, L.; Cardinal, R.; de Champlain, J. 1997: Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat Hypertension 30(2 Pt 1): 278-287Pirrelli, A.; Pieri, R.; Dolce, E. 1976: Correlations between plasmatic renin and aldosterone in essential arterial hypertension with sympathetic hyperactivity Bollettino Della Societa Italiana di Cardiologia 21(3): 511-515
Newton, G.E.; Parker, J.D. 1996: Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure Circulation 94(3): 353-358
Diekmann, L.; Höhfeld, J. 1971: Effects of adrenergic beta receptor blockaders on centrally caused sympathetic hyperactivity in children Arztliche Forschung 25(10): 335-340
Wnuk, R.; Kokot, F. 1991: Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension Endokrynologia Polska 42(3): 421-427
Prikryl, P.; Vondrácek, V.; Prásek, J.; Rysánek, K.; Kunovská, V.; Mayer, P. 1985: Beta-adrenergic receptors in healthy individuals and in patients with essential hypertension Vnitrni Lekarstvi 31(2): 142-149
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881
Osborn, J.L.; DiBona, G.F.; Thames, M.D. 1981: Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation Journal of Pharmacology and Experimental Therapeutics 216(2): 265-269
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367
Cugini, P.; Halberg, F.; Lucia, P.; Murano, G.; Letizia, C.; Scavo, D. 1986: Role of the macula densa and beta-adrenergic system in the control of the circadian rhythm of renin and aldosterone Recenti Progressi in Medicina 77(12): 570-572
Li, N-fang.; Zhou, L.; Li, T.; Wang, H-mei.; Liu, H.; Hu, J-li. 2007: Association between the +491C/T polymorphism of beta2-adrenergic receptor gene and risk of essential hypertension in Kazakns of Xinjiang Zhonghua Xin Xue Guan Bing Za Zhi 35(8): 706-709
Bühler, F.R.; Lütold, B.E. 1976: Beta adrenergic receptor blockade as a basis for the treatment of hypertension Therapeutische Umschau. Revue Therapeutique 33(5): 336-346
Brecht, H.M.; Vlachoyannis, J.; Musil, H.A.; Ernst, W.; Weismüller, G.; Schoeppe, W. 1975: Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1035-1038
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Limone, P.; D'Alessandro, V.; Rainero, I.; Ambrogio, C.; Pinessi, L.; De Gennaro, T.; Molinatti, G.M. 1993: Adrenergic regulation of alpha-MSH secretion in man: evidence for a stimulatory role of beta-receptors Acta Endocrinologica 128(2): 150-155
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311